| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $5,513,155 ) |
| | 2026 | 2026 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R01EY034672 | Role of Macrophages in ocular GVHD | 000 | 4 | NIH | 12/4/2025 | $342,000 |
| | 2026 | 2026 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | K01DK125448 | The Role of Thyroglobulin in Thyroid Hormone Synthesis | 000 | 6 | NIH | 12/10/2025 | $150,832 |
| | 2026 | 2026 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R01AG054442 | Testing Hypothesized Pathways Linking Infection, Physical Activity, Apoe Genotype, And Biological Sex To Low Dementia Prevalence And Reduced Brain Atrophy In Two Native American Populations | 000 | 7 | NIH | 5/12/2026 | $2,537,279 |
| | 2026 | 2026 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R01CA303584 | Development of small molecule selective inhibitors of neuronal nitric oxide synthase (nNOS) for melanoma treatment | 000 | 2 | NIH | 5/19/2026 | $610,266 |
| | 2026 | 2026 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R01AG085724 | Efficacy, safety, and mechanisms of brain penetrable erythropoietin in Alzheimer’s disease mouse models | 000 | 3 | NIH | 3/30/2026 | $342,000 |
| | 2026 | 2026 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R15CA309584 | Peptide-drug conjugates targeting EGFR for improved efficacy of chemotherapy | 000 | 1 | NIH | 3/27/2026 | $534,925 |
| | 2026 | 2026 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R01DK144429 | Thyroid Hormone Signaling in a Triiodothyronine-Only Hormonal Environment | 000 | 2 | NIH | 5/26/2026 | $346,250 |
| | 2026 | 2026 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R37CA309117 | Tracking Residential Air Quality to Quit Smoking | 000 | 1 | NIH | 6/11/2026 | $649,603 |
| | 2026 | 2025 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R01NS145389 | Molecular mechanism for pharmacological activation of KCa2 channels | 000 | 1 | NIH | 5/6/2026 | $0 |
| | 2026 | 2024 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R15NS130420 | Channelopathy of KCa2.3 and Zimmermann-Laband syndrome | 000 | 1 | NIH | 1/29/2026 | $0 |
| | 2026 | 2024 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R03AI168826 | Mechanisms and In Vivo Activity of a Next Generation Daptomycin Antibiotic | 000 | 2 | NIH | 4/22/2026 | $0 |
| | 2026 | 2024 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R01AG062840 | A Brain Penetrating Bi-functional Transferrin Receptor Antibody-TNF-alpha Decoy Receptor Fusion Protein for Alzheimer's Disease | 000 | 6 | NIH | 6/28/2026 | $0 |
| | 2026 | 2023 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R01HL147311 | Cilia-specific cAMP plays a major role in aneurysm | 000 | 4 | NIH | 12/18/2025 | $0 |
| | 2026 | 2023 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R15HD110941 | AI-based Fall-Risk Assessment during Daily Activities in Post Stroke Survivors using Smartphones | 000 | 1 | NIH | 4/23/2026 | $0 |
|
| Issue Date FY: 2025 ( Subtotal = $7,151,210 ) |
| | 2025 | 2025 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R01CA303584 | Development of small molecule selective inhibitors of neuronal nitric oxide synthase (nNOS) for melanoma treatment | 000 | 1 | NIH | 6/23/2025 | $610,415 |
| | 2025 | 2025 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R15DK142149 | Extracellular Vesicles from Enterocytes are Mediators of Inflammation in IBD | 000 | 1 | NIH | 8/20/2025 | $458,047 |
| | 2025 | 2025 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R01AG054442 | Testing Hypothesized Pathways Linking Infection, Physical Activity, Apoe Genotype, And Biological Sex To Low Dementia Prevalence And Reduced Brain Atrophy In Two Native American Populations | 000 | 6 | NIH | 8/14/2025 | $2,770,736 |
| | 2025 | 2025 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R01AG054442 | Testing Hypothesized Pathways Linking Infection, Physical Activity, Apoe Genotype, And Biological Sex To Low Dementia Prevalence And Reduced Brain Atrophy In Two Native American Populations | 000 | 6 | NIH | 8/14/2025 | $112,357 |
| | 2025 | 2025 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R01AG085724 | Efficacy, safety, and mechanisms of brain penetrable erythropoietin in Alzheimer’s disease mouse models | 000 | 2 | NIH | 3/11/2025 | $307,800 |
| | 2025 | 2025 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R01AG085724 | Efficacy, safety, and mechanisms of brain penetrable erythropoietin in Alzheimer’s disease mouse models | 001 | 2 | NIH | 6/18/2025 | $27,360 |
| | 2025 | 2025 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R01NS145389 | Molecular mechanism for pharmacological activation of KCa2 channels | 000 | 1 | NIH | 7/30/2025 | $580,619 |
| | 2025 | 2025 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R01CA264913 | Defining the role of plasma cells in the establishment of KSHV infection in human tonsil | 000 | 5 | NIH | 9/2/2025 | $585,145 |
| | 2025 | 2025 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R01DK144429 | Thyroid Hormone Signaling in a Triiodothyronine-Only Hormonal Environment | 000 | 1 | NIH | 9/11/2025 | $346,250 |
| | 2025 | 2025 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R15CA301437 | Peptide-Doxorubicin Conjugates for Mitigating Cardiotoxicity and Overcoming Drug Resistance in Cancer | 000 | 1 | NIH | 6/19/2025 | $415,500 |
| | 2025 | 2025 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R01HL166175 | Positive Affect and Pediatric Asthma: An Innovative Positive Psychology Model to Improve Asthma Management and Health | 000 | 3 | NIH | 9/1/2025 | $579,476 |
| | 2025 | 2025 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | K01DK125448 | The Role of Thyroglobulin in Thyroid Hormone Synthesis | 000 | 5 | NIH | 11/22/2024 | $150,832 |
| | 2025 | 2025 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R01EY034672 | Role of Macrophages in ocular GVHD | 000 | 3 | NIH | 12/4/2024 | $342,000 |
| | 2025 | 2024 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R03HD107630 | Determining the effects of increased demands for voluntary adjustments on the neuromuscular control of walking post-stroke | 000 | 2 | NIH | 9/13/2025 | -$779 |
| | 2025 | 2024 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | K01MD018417 | Social and Environmental Determinants of Breast Cancer Survivorship: The Black Breast Cancer Survivors Intervention | 000 | 2 | NIH | 8/17/2025 | -$123,893 |
| | 2025 | 2024 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | K01MD018417 | Social and Environmental Determinants of Breast Cancer Survivorship: The Black Breast Cancer Survivors Intervention | 002 | 2 | NIH | 8/21/2025 | $0 |
| | 2025 | 2023 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R03TR004248 | A precision medicine approach to identify walking phenotypes and rehabilitation targets after injury | 000 | 3 | NIH | 8/20/2025 | -$511 |
| | 2025 | 2023 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R01CA239590 | Identifying susceptibility factors for KSHV infection in human tonsil | 000 | 5 | NIH | 7/25/2025 | -$7,506 |
| | 2025 | 2022 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R01GM107094 | Molecular signal transduction of cAMP compartments | 000 | 9 | NIH | 3/13/2025 | -$2,638 |
|
| Issue Date FY: 2024 ( Subtotal = $5,819,220 ) (Continued on the next page) |
| | 2024 | 2024 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | K01DK125448 | The Role of Thyroglobulin in Thyroid Hormone Synthesis | 000 | 4 | NIH | 10/27/2023 | $150,672 |
| | 2024 | 2024 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R01EY034672 | Role of Macrophages in ocular GVHD | 000 | 2 | NIH | 12/11/2023 | $342,000 |
| | 2024 | 2024 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R01AG085724 | Efficacy, safety, and mechanisms of brain penetrable erythropoietin in Alzheimer’s disease mouse models | 000 | 1 | NIH | 5/30/2024 | $342,000 |
| | 2024 | 2024 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R01AG054442 | Testing Hypothesized Pathways Linking Infection, Physical Activity, Apoe Genotype, And Biological Sex To Low Dementia Prevalence And Reduced Brain Atrophy In Two Native American Populations | 001 | 5 | NIH | 6/13/2024 | $229,301 |
| | 2024 | 2024 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R01AG054442 | Testing Hypothesized Pathways Linking Infection, Physical Activity, Apoe Genotype, And Biological Sex To Low Dementia Prevalence And Reduced Brain Atrophy In Two Native American Populations | 000 | 5 | NIH | 4/30/2024 | $3,062,013 |
| | 2024 | 2024 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R03HD107630 | Determining the effects of increased demands for voluntary adjustments on the neuromuscular control of walking post-stroke | 000 | 2 | NIH | 5/27/2024 | $142,513 |
| | 2024 | 2024 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R03AI168826 | Mechanisms and In Vivo Activity of a Next Generation Daptomycin Antibiotic | 001 | 2 | NIH | 5/10/2024 | $6,900 |
| | 2024 | 2024 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R03AI168826 | Mechanisms and In Vivo Activity of a Next Generation Daptomycin Antibiotic | 000 | 2 | NIH | 10/25/2023 | $62,100 |
| | 2024 | 2024 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R15NS130420 | Channelopathy of KCa2.3 and Zimmermann-Laband syndrome | 000 | 1 | NIH | 3/12/2024 | $434,024 |
| | 2024 | 2024 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R01CA264913 | Defining the role of plasma cells in the establishment of KSHV infection in human tonsil | 000 | 4 | NIH | 8/27/2024 | $104,855 |
| | 2024 | 2024 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R01AG062840 | A Brain Penetrating Bi-functional Transferrin Receptor Antibody-TNF-alpha Decoy Receptor Fusion Protein for Alzheimer's Disease | 000 | 6 | NIH | 4/17/2024 | $245,000 |
| | 2024 | 2024 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R01HL166175 | Positive Affect and Pediatric Asthma: An Innovative Positive Psychology Model to Improve Asthma Management and Health | 000 | 2 | NIH | 6/26/2024 | $565,206 |
| | 2024 | 2024 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | K01MD018417 | Social and Environmental Determinants of Breast Cancer Survivorship: The Black Breast Cancer Survivors Intervention | 000 | 2 | NIH | 7/11/2024 | $124,114 |
| | 2024 | 2023 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | K01DK125448 | The Role of Thyroglobulin in Thyroid Hormone Synthesis | 002 | 3 | NIH | 11/29/2023 | $25,730 |
|
